SONELOKIMAB

UNII:	LEN0OCZ4SH
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SONELOKIMAB
GSRS Full Record:	LEN0OCZ4SH i

1414386-05-2
ALX-0761
ALX0761
Immunoglobulin G, anti-(human interleukin 17F) (human-Lama glama nanobody clone IL17MS3063 γ-chain V-D-J region fragment) fusion protein with peptide (synthetic 9-amino acid linker) fusion protein with immunoglobulin G, anti-(human serum albumin) (human-Lama glama nanobody clone ALB-11 γ-chain V-D-J region fragment) fusion protein with peptide (synthetic 9-amino acid linker) fusion protein with immunoglobulin G, anti-(human interleukin 17A) (human-Lama glama nanobody clone IL17MS3069 γ-chain V-D-J region fragment)
M-1095
M-1095 (ANTI-INTERLEUKIN (IL)-17A/F SINGLE-DOMAIN ANTIBODY)
M1095
MSB 0010841
MSB-010841
SONELOKIMAB [USAN]
Sonelokimab
Sonelokimab [WHO-DD]
sonelokimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SONELOKIMAB

Synonyms and Mappings

Resources